What is fish oil?
Fish oil is the go-to source for two long-chain omega-3 (a.k.a. n-3) polyunsaturated fatty acids: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Fish oil can be consumed in the diet (from foods like salmon or anchovies), and is also available as a dietary supplement and as a prescription drug. The role of fish oil in cardiovascular disease, cancer, and many other conditions is a field of considerable interest and research.[1]
According to recent analyses of NHANES, over 20% of the population in the United States takes an omega-3-containing dietary supplement.[2]
What are fish oil’s main benefits?
Fish oil is best known for its ability to reduce triglyceride levels in the blood, for which prescription fish oil is best studied.[3] Fish oil also seems to modestly reduce blood pressure, especially in people with hypertension.[4] Despite this, a meta-analysis of large clinical trials shows that taking fish oil for at least 1 year does not reduce the rate of cardiovascular events.[5] Most analyses suggest a modest benefit of fish oil for depression,[6][7][8][9] but this benefit may be too small to make a difference in people with major depressive disorder.[8][10] Limited evidence suggests that fish oil may have some benefit for inflammatory conditions like systemic lupus erythematosus and rheumatoid arthritis.[11]
What are fish oil’s main drawbacks?
Fish oil is usually well-tolerated and safe. Common side effects from taking fish oil supplements include stomach pain, fishy breath and burps, heartburn, nausea, and diarrhea. Also, some fish oil formulations have been linked to increased levels of low-density lipoprotein (LDL) cholesterol. Fish oil supplements are not strictly regulated, and some may contain contaminants, oxidized fatty acids, saturated fats, and other impurities that may reduce the overall benefit of the supplement. Fish oil has antiplatelet effects, although most clinical research has not found that supplementation with fish oil increased bleeding risk. A large 5-year study in Japan did find a small increase in bleeding in people taking prescription eicosapentaenoic acid (EPA), though.[3]
How does fish oil work?
Fish oil reduces triglyceride levels by decreasing triglyceride-rich lipoprotein synthesis and release by the liver. It may also increase clearance of triglycerides by upregulating the lipoprotein lipase enzyme.[3] EPA and DHA from fish oil are usually initially incorporated into the phospholipid layer of cell membranes in platelets, neutrophils, and red blood cells. EPA especially seems to stabilize cell membranes and inhibit lipid oxidation, which can help regulate vascular tone, improve cell signaling, and reduce inflammation.[12]
What are other names for Fish Oil
- Omega-3 fatty acids
- Omega-3
- Omega 3
- N-3 Fatty Acids
- Alpha-Linolenic Acid (the plant-based omega-3)
Dosage information
Fish oil doses vary depending on the goal of supplementation. For general health, 250 mg of combined EPA and DHA is the minimum dose and can be obtained via fish intake. The American Heart Association recommends 1 g daily.
Since fish oil is a combination of two different fatty acids, these numbers reflect a combined total. Total eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) consumption should come from a mix of real food and supplements. The more EPA and DHA is provided by the diet, the less supplementation is required.
Fish oil can be taken throughout the day. To minimize the "fish burp" taste, take fish oil with meals.
Pregnant women should increase their intake of DHA by at least 200mg a day, as long as there is no risk of elevated mercury levels.
Frequently asked questions
Fish oil is the go-to source for two long-chain omega-3 (a.k.a. n-3) polyunsaturated fatty acids: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Fish oil can be consumed in the diet (from foods like salmon or anchovies), and is also available as a dietary supplement and as a prescription drug. The role of fish oil in cardiovascular disease, cancer, and many other conditions is a field of considerable interest and research.[1]
According to recent analyses of NHANES, over 20% of the population in the United States takes an omega-3-containing dietary supplement.[2]
Fish oil is best known for its ability to reduce triglyceride levels in the blood, for which prescription fish oil is best studied.[3] Fish oil also seems to modestly reduce blood pressure, especially in people with hypertension.[4] Despite this, a meta-analysis of large clinical trials shows that taking fish oil for at least 1 year does not reduce the rate of cardiovascular events.[5] Most analyses suggest a modest benefit of fish oil for depression,[6][7][8][9] but this benefit may be too small to make a difference in people with major depressive disorder.[8][10] Limited evidence suggests that fish oil may have some benefit for inflammatory conditions like systemic lupus erythematosus and rheumatoid arthritis.[11]
A meta-analysis of 35 small, randomized trials found that fish oil can slightly improve depression when compared to control. However, this improvement may be too small to be noticeable. Also, adding fish oil to antidepressant medication seems to be more beneficial than antidepressant treatment alone.[8] Fish oil incorporates into the cell membrane phospholipid layer, increasing its fluidity and permeability, which in turn might reduce inflammation and attenuate depressive symptoms. Another meta-analysis suggested that doses of 1-2 grams daily containing ≥60% proportion of total EPA + DHA seem to be especially beneficial.[9]
The short answer is “yes”, but it ultimately depends on your goal. For the purpose of covering the minimum amount of omega-3 fatty acids required for general health, it’s not necessary to consume fish or fish oil; you can just eat flaxseed.
Flaxseed is a rich source of alpha-linolenic acid|alpha-linolenic acid (ALA), the only essential omega-3 fatty acid (i.e., the only omega-3 that can’t be synthesized by the body). Following ingestion, ALA is converted into the longer chain omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the same fatty acids found in fish oil.
Animal-based foods are the primary sources of EPA and DHA in the diet. Consequently, vegetarians and vegans consume trivial amounts of these omega-3 fatty acids,[18] and their blood levels of EPA and DHA tend to be lower than meat-eaters'.[19]
Despite the near exclusion of EPA and DHA from plant-based diets, these diets are not associated with adverse health effects or impairments in cognitive development,[20] which suggests that the average ALA intake of people following these diets allows for sufficient endogenous synthesis of EPA and DHA. Furthermore, the consumption of a healthy plant-based diet is associated with a variety of health benefits, such as a reduced risk of chronic diseases like cardiovascular disease and type 2 diabetes.[21]
However, while it’s evident that the average person can cover their basic omega-3 fatty acid needs through ALA-rich foods (like flaxseed) alone, that doesn’t mean that ALA-only intake is optimal, at least with respect to certain health outcomes.
Higher intakes of EPA and DHA are associated with a number of health benefits,[22] and higher blood levels are, too. A higher blood level of EPA and DHA is associated with a reduced risk of all-cause mortality and death from cardiovascular disease or cancer,[23] as well as a reduced risk of developing type 2 diabetes.[24] Higher blood levels of EPA and DHA might also be protective against cognitive decline and dementia,[22] but more high-quality studies are needed to confirm whether this is the case.
Only consuming flaxseed may mean missing out on the potential benefits of higher-than-adequate levels of EPA and DHA, because the available evidence suggests that supplementing with ALA does not significantly increase the blood level of EPA and DHA.[25][26] (To be more specific, supplementing with ALA seems to increase the blood level of EPA to a small degree, but it either doesn’t affect or even slightly decreases the blood level of DHA, typically resulting in no effect on the combined level of EPA and DHA.[27])
As such, to maximize certain health outcomes, it might be best to consume direct sources of EPA and DHA — either in the form of fatty fish or fish oil, or, for vegetarians and vegans, in the form of algal oil — but further research is needed to confirm this.[28]
Fish oil is usually well-tolerated and safe. Common side effects from taking fish oil supplements include stomach pain, fishy breath and burps, heartburn, nausea, and diarrhea. Also, some fish oil formulations have been linked to increased levels of low-density lipoprotein (LDL) cholesterol. Fish oil supplements are not strictly regulated, and some may contain contaminants, oxidized fatty acids, saturated fats, and other impurities that may reduce the overall benefit of the supplement. Fish oil has antiplatelet effects, although most clinical research has not found that supplementation with fish oil increased bleeding risk. A large 5-year study in Japan did find a small increase in bleeding in people taking prescription eicosapentaenoic acid (EPA), though.[3]
There are some mixed views on whether fish oil can cause abnormal heart rhythms or not. Generally speaking, most healthy people don’t need to worry: A meta-analysis of 30 randomized studies and 77,990 patients shows that taking fish oil does not affect the risk of atrial fibrillation.[13] However, in people who have (or are at risk for) heart disease, there’s a possibility that fish oil can increase the risk of new-onset atrial fibrillation. Several meta-analyses of randomized studies at least one year long in people with or at risk for cardiovascular disease show that fish oil can increase the risk of new-onset atrial fibrillation compared to control.[14][15][16] It’s important to note that, while this increase in risk is statistically significant, it’s still small in absolute terms and there is no known mechanism to explain this risk.
For most people, regular fish oil supplements do not affect bleeding risk. One meta-analysis of 11 randomized studies with over 80,000 patients concluded (with low certainty) that fish oil does not increase bleeding risk,[13] and another meta-analysis, which stratified by type of fish oil supplement, reported similar findings. Interestingly, the latter meta-analysis noted that EPA-only supplements did increase bleeding risk compared to control, but the absolute increase in risk was very small: about 0.5%, suggesting that for every 200 people taking an EPA-only supplement, one might experience bleeding.[17]
Fish oil reduces triglyceride levels by decreasing triglyceride-rich lipoprotein synthesis and release by the liver. It may also increase clearance of triglycerides by upregulating the lipoprotein lipase enzyme.[3] EPA and DHA from fish oil are usually initially incorporated into the phospholipid layer of cell membranes in platelets, neutrophils, and red blood cells. EPA especially seems to stabilize cell membranes and inhibit lipid oxidation, which can help regulate vascular tone, improve cell signaling, and reduce inflammation.[12]
Update History
Updated one FAQ
Full page update
Research written by
Edited by
Reviewed by
Major FAQ and database update
Research written by
Edited by
Reviewed by
Research Breakdown
References
- ^Mozaffarian D, Wu JHOmega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical eventsJ Am Coll Cardiol.(2011 Nov 8)
- ^Cowan AE, Tooze JA, Gahche JJ, Eicher-Miller HA, Guenther PM, Dwyer JT, Potischman N, Bhadra A, Carroll RJ, Bailey RLTrends in Overall and Micronutrient-Containing Dietary Supplement Use in US Adults and Children, NHANES 2007-2018.J Nutr.(2023-Jan-14)
- ^Ann C Skulas-Ray, Peter W F Wilson, William S Harris, Eliot A Brinton, Penny M Kris-Etherton, Chesney K Richter, Terry A Jacobson, Mary B Engler, Michael Miller, Jennifer G Robinson, Conrad B Blum, Delfin Rodriguez-Leyva, Sarah D de Ferranti, Francine K Welty, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical CardiologyOmega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart AssociationCirculation.(2019 Sep 17)
- ^Zhang X, Ritonja JA, Zhou N, Chen BE, Li XOmega-3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials.J Am Heart Assoc.(2022-Jun-07)
- ^Aung T, Halsey J, Kromhout D, Gerstein HC, Marchioli R, Tavazzi L, Geleijnse JM, Rauch B, Ness A, Galan P, Chew EY, Bosch J, Collins R, Lewington S, Armitage J, Clarke R, Omega-3 Treatment Trialists’ CollaborationAssociations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 IndividualsJAMA Cardiol.(2018 Mar 1)
- ^Liao Y, Xie B, Zhang H, He Q, Guo L, Subramaniapillai M, Fan B, Lu C, Mclntyer RSEfficacy of omega-3 PUFAs in depression: A meta-analysisTransl Psychiatry.(2019 Aug 5)
- ^Simon MS, Arteaga-Henríquez G, Fouad Algendy A, Siepmann T, Illigens BMWAnti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses.Neuropsychiatr Dis Treat.(2023)
- ^Katherine M Appleton, Philip D Voyias, Hannah M Sallis, Sarah Dawson, Andrew R Ness, Rachel Churchill, Rachel PerryOmega-3 fatty acids for depression in adultsCochrane Database Syst Rev.(2021 Nov 24)
- ^Christos F Kelaiditis, E Leigh Gibson, Simon C DyallEffects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trialsProstaglandins Leukot Essent Fatty Acids.(2023 May)
- ^Memarpouri A, van der Does W, Molendijk MLn-3 PUFAs for depression: treatment effect or absence-of-placebo effect?Transl Psychiatry.(2022-Jul-26)
- ^Gwinnutt JM, Wieczorek M, Rodríguez-Carrio J, Balanescu A, Bischoff-Ferrari HA, Boonen A, Cavalli G, de Souza S, de Thurah A, Dorner TE, Moe RH, Putrik P, Silva-Fernández L, Stamm T, Walker-Bone K, Welling J, Zlatković-Švenda M, Guillemin F, Verstappen SMMEffects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.RMD Open.(2022-Jun)
- ^Brosolo G, Da Porto A, Marcante S, Picci A, Capilupi F, Capilupi P, Bertin N, Vivarelli C, Bulfone L, Vacca A, Catena C, Sechi LAOmega-3 Fatty Acids in Arterial Hypertension: Is There Any Good News?Int J Mol Sci.(2023-May-30)
- ^Asmaa S Abdelhamid, Tracey J Brown, Julii S Brainard, Priti Biswas, Gabrielle C Thorpe, Helen J Moore, Katherine Ho Deane, Carolyn D Summerbell, Helen V Worthington, Fujian Song, Lee HooperOmega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseCochrane Database Syst Rev.(2020 Feb 29)
- ^Baris Gencer, Luc Djousse, Omar T Al-Ramady, Nancy R Cook, JoAnn E Manson, Christine M AlbertEffect of Long-Term Marine Omega-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-AnalysisCirculation.(2021 Oct 6)
- ^Bae JH, Lim H, Lim SThe Potential Cardiometabolic Effects of Long-Chain ω-3 Polyunsaturated Fatty Acids: Recent Updates and Controversies.Adv Nutr.(2023-Jul)
- ^Marco Lombardi, Salvatore Carbone, Marco Giuseppe Del Buono, Juan Guido Chiabrando, Giovanni Maria Vescovo, Massimiliano Camilli, Rocco Antonio Montone, Rocco Vergallo, Antonio Abbate, Giuseppe Biondi-Zoccai, Dave L Dixon, Filippo CreaOmega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trialsEur Heart J Cardiovasc Pharmacother.(2021 Jul 23)
- ^Safi U Khan, Ahmad N Lone, Muhammad Shahzeb Khan, Salim S Virani, Roger S Blumenthal, Khurram Nasir, Michael Miller, Erin D Michos, Christie M Ballantyne, William E Boden, Deepak L BhattEffect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysisEClinicalMedicine.(2021 Jul 8)
- ^Nicole Neufingerl, Ans EilanderNutrient Intake and Status in Adults Consuming Plant-Based Diets Compared to Meat-Eaters: A Systematic ReviewNutrients.(2021 Dec 23)
- ^Bonny Burns-Whitmore, Erik Froyen, Celine Heskey, Temetra Parker, Gregorio San PabloAlpha-Linolenic and Linoleic Fatty Acids in the Vegan Diet: Do They Require Dietary Reference Intake/Adequate Intake Special Consideration?Nutrients.(2019 Oct 4)
- ^Burdge GCα-linolenic acid interconversion is sufficient as a source of longer chain ω-3 polyunsaturated fatty acids in humans: An opinion.Lipids.(2022-Nov)
- ^Wang Y, Liu B, Han H, Hu Y, Zhu L, Rimm EB, Hu FB, Sun QAssociations between plant-based dietary patterns and risks of type 2 diabetes, cardiovascular disease, cancer, and mortality - a systematic review and meta-analysis.Nutr J.(2023-Oct-04)
- ^Troesch B, Eggersdorfer M, Laviano A, Rolland Y, Smith AD, Warnke I, Weimann A, Calder PCExpert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition.Nutrients.(2020-Aug-24)
- ^William S Harris, Nathan L Tintle, Fumiaki Imamura, Frank Qian, Andres V Ardisson Korat, Matti Marklund, Luc Djoussé, Julie K Bassett, Pierre-Hugues Carmichael, Yun-Yu Chen, Yoichiro Hirakawa, Leanne K Küpers, Federica Laguzzi, Maria Lankinen, Rachel A Murphy, Cécilia Samieri, Mackenzie K Senn, Peilin Shi, Jyrki K Virtanen, Ingeborg A Brouwer, Kuo-Liong Chien, Gudny Eiriksdottir, Nita G Forouhi, Johanna M Geleijnse, Graham G Giles, Vilmundur Gudnason, Catherine Helmer, Allison Hodge, Rebecca Jackson, Kay-Tee Khaw, Markku Laakso, Heidi Lai, Danielle Laurin, Karin Leander, Joan Lindsay, Renata Micha, Jaako Mursu, Toshiharu Ninomiya, Wendy Post, Bruce M Psaty, Ulf Risérus, Jennifer G Robinson, Aladdin H Shadyab, Linda Snetselaar, Aleix Sala-Vila, Yangbo Sun, Lyn M Steffen, Michael Y Tsai, Nicholas J Wareham, Alexis C Wood, Jason H Y Wu, Frank Hu, Qi Sun, David S Siscovick, Rozenn N Lemaitre, Dariush Mozaffarian, Fatty Acids and Outcomes Research Consortium (FORCE)Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studiesNat Commun.(2021 Apr 22)
- ^Qian F, Ardisson Korat AV, Imamura F, Marklund M, Tintle N, Virtanen JK, Zhou X, Bassett JK, Lai H, Hirakawa Y, Chien KL, Wood AC, Lankinen M, Murphy RA, Samieri C, Pertiwi K, de Mello VD, Guan W, Forouhi NG, Wareham N, Hu ICFB, Riserus U, Lind L, Harris WS, Shadyab AH, Robinson JG, Steffen LM, Hodge A, Giles GG, Ninomiya T, Uusitupa M, Tuomilehto J, Lindström J, Laakso M, Siscovick DS, Helmer C, Geleijnse JM, Wu JHY, Fretts A, Lemaitre RN, Micha R, Mozaffarian D, Sun Q,n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies.Diabetes Care.(2021-May)
- ^Katie E Lane, Megan Wilson, Teuta G Hellon, Ian G DaviesBioavailability and conversion of plant based sources of omega-3 fatty acids - a scoping review to update supplementation options for vegetarians and vegansCrit Rev Food Sci Nutr.(2021 Feb 12)
- ^Dempsey M, Rockwell MS, Wentz LMThe influence of dietary and supplemental omega-3 fatty acids on the omega-3 index: A scoping review.Front Nutr.(2023)
- ^Baker EJ, Miles EA, Burdge GC, Yaqoob P, Calder PCMetabolism and functional effects of plant-derived omega-3 fatty acids in humansProg Lipid Res.(2016 Oct)
- ^Harris WSAchieving optimal n-3 fatty acid status: the vegetarian's challenge... or not.Am J Clin Nutr.(2014-Jul)